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Allergic complications following pacemaker insertion are rare. However, when they do occur, they 
usually mimic pacemaker infection, which may lead to multiple device replacements and increased 
morbidity burden (1, 2). Reactions can take the form of dermatitis localized in the area above 
implantation and, uncommonly, generalized or remote site dermatitis (1, 2).  
 
CASE REPORT 
In 2011, a 64-year-old female had a pacemaker implanted in the left pectoral region to treat 
intermittent second-degree AV block (Mobitz II) and presyncope. The pacemaker was made by 
Medtronic (DDD Medtronic Sensia SED01). The device pulse generator, device controller-monitor and 
leads were coated with various materials (polyurethane, polysulfone, silicone rubber, titanium, 
parylene coated titanium, platinum iridium, nickel MP35N) to reduce infections and reaction. The 
leads were made of nickel alloy (MP35N) isolated with silicone rubber. 
Ten months later, the patient presented with localized swelling, redness and purulent drainage in the 
implanted area. She had no fever and laboratory data showed no signs of infection. Bacterial swabs 
and cultures of the material taken were negative. Over the next two years, she was treated with 
many different antibiotics. Repeated bacterial swabs were mostly negative. Coagulase-negative 
staphylococci (Staphylococcus species) were isolated on two occasions. Between 2013 and 2014, the 
patient underwent five repositions of the old pacemaker system and re-implantation to the different 
site on the left chest wall. Every time, 6 – 8 weeks after the procedure, the skin overlying the 
generator became “infected” and the patient received antibiotics, despite negative bacterial swabs 
and/or cultures. During that period, the patient felt constantly tired; had palpitations and vertigo; 
and could not perform everyday activities. Her ECG showed persistent signs of arrhythmia. Her 
medical history revealed costume jewelry eczema for the past 20 years. In 2009 she had 
hysterectomy and adnexectomy due to uterine fibroids. For years she has been treated for arterial 
hypertension, bronchial asthma and chronic gastritis. 
The patient presented to our Department because of persistent vulvar pruritus that has begun in 
2011, a few months after the implantation of the pacemaker. She was treated with various local 
corticosteroids and neutral creams, which temporarily relieved the symptoms. Clinical examination 
revealed vulvar eczema (chronic lichen simplex) and persistent “infection” on the left chest wall 
(figure 1). We performed patch test to the baseline series, titanium dioxide, titanium, titanium 
nitride, molybdenum and methyl-methacrylate. Patch testing to nickel sulfate (5% pet) showed a 
positive reaction “+” at day 2 and “++” at day 3 and day 7. The specific manufacturer’s patch test 
substances were not tested because they were not available to us. In the lymphocyte transformation 
test (LTT), the patient’s lymphocytes showed markedly enhanced proliferation in vitro to nickel.  
The prednisone therapy (initial dose of 30 mg tapered down over 2 weeks) had no effect on the left 
chest wall skin lesion, however vulvar eczema temporarily disappeared.  
We suspected pacemaker systemic contact allergy, and we recommended removal of all pacemaker 
systems and the implantation of a new pacemaker system. 
The removal of the old pacemaker device and placement of a new one (the same brand and type of 
pacemaker device but nickel-free) resulted in the complete resolution of her symptoms: vulvar 
eczema cleared and skin lesion on the left chest wall disappeared. At the follow-up controls after 3, 6 
and 12 months, in vitro hyper-reactivity to nickel disappeared. The patient has now been free of 
cardiac and dermatological symptoms for over 18 months. 
 
DISCUSSION 
Pacemaker component allergy is a relatively rare cause of erythema, pain and swelling at the site of 
an implanted pacemaker (3). Clinical presentation includes skin lesions that are often confused with 
pacemaker infection or necrosis (4, 5). Clinicians tend to suspect a low-grade bacterial infection prior 
to performing an allergy test to confirm the presence of an allergy. Chua et al. have showed that 32% 
of patients with clinical signs and symptoms of implantable electrophysiological cardiac devices 
infection had negative tissue and swab cultures, and they responded well to total device removal and 
antibiotics (6). 
The time taken to develop sensitivity varies from months to years. The exact pathological mechanism 
is unclear, but delayed-type hypersensitivity reaction is possible (2).  
Pacemakers are made of two implanted components: generator and leads. Generators are mostly 
covered with titanium capsule (2). Leads are attached to the capsule through the pacemaker header 
(2). In our case, leads were insulated wires made of MP35N alloy, composed of nickel, cobalt, 
chromium, and molybdenum. MP35N is an age-hardenable nickel-cobalt base alloy with a unique 
combination of properties: ultra-high strength, toughness, ductility and outstanding corrosion 
resistance (7). There have been several reported cases of allergic sensitivity to these encasing 
materials, including titanium, nickel, polyurethane, epoxy, mercury, cadmium, chromium, silicone, 
polychloroparaxylene, and cobalt (3, 4, 8-14).  
Nickel is the most frequent allergen found when patch-testing patients with allergic contact 
dermatitis. Our patient had vulvar eczema that started a few months after the pacemaker 
implantation. Vien and Menné described a 37-year-old woman who had severe anogenital 
dermatitis, which was suspected to be a systemic contact dermatitis due to nickel (15). Her patch test 
showed a “++” reaction to nickel. Placebo-controlled oral challenge with 2.5 mg nickel produced a 
severe flare of her anogenital dermatitis after 2 days. Following a low-nickel diet for 2 months, the 
dermatitis disappeared (15). In another patient, lichenified plaques on forearms, thighs, and legs 
developed 2 years after pacemaker insertion (16). A stainless steel screw was exposed to tissues. 
That patient’s patch test results were positive to nickel, cobalt, and chromate (16). Landwehr and van 
Ketel described a patient with a long history of hand dermatitis and with sensitivity to metal objects 
in whom pompholyx developed two days after the implantation of a pacemaker with a stainless steel 
case (12). Her patch test showed a positive reaction to nickel sulphate (12). 
The patch test is a gold standard for the evaluation of delayed type allergy. The LTT shows reactions 
to circulating lymphocytes, and it more accurately reflects immune reactions within the body (1, 17). 
Fifty-six individuals with Ti implants, systemic symptoms and negative patch test results had a 
positive Ti LTT (17). In 54 cases, the patients had complete resolution of symptoms following the 
removal of metal implants (17). The same happened in our case where we suspected nickel systemic 
contact sensitivity. Thomas at al reported about a patient in whom impaired fracture healing and 
eczema localized to the perioperative area developed following titanium-based osteosynthesis (18). 
Patch tests to the metals were negative, but LTT showed markedly enhanced proliferation in vitro to 
titanium. After removal of the titanium material, the fracture healed and the eczema cleared. As in 
the Thomas study, we also noticed that in vitro hyper-reactivity to nickel disappeared after the 
pacemaker re-implantation.  
 
 
CONCLUSION 
Contact allergy to pacemaker is often unrecognized. A failure to diagnose may lead to multiple 
unnecessary surgical interventions. Once infection has been excluded, allergy testing must be 
performed. Patch test should be performed to the baseline allergens and the specific biomaterials 
used in device. The role of LTT is not well defined, but it could be a useful tool when systemic metal 
sensibility is suspected. Although pacemaker contact sensitivity is rare, its recognition is very 
important to the pacemaker-dependent patient. 
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Figure 1  
A 64-year-old female patient with 4 years’ history of repeated local swelling, redness and purulent 
drainage on the site of pacemaker implanted area 
